125 related articles for article (PubMed ID: 6252027)
21. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
Mela F; Marti M; Bido S; Cenci MA; Morari M
Neurobiol Dis; 2012 Jan; 45(1):573-82. PubMed ID: 22001605
[TBL] [Abstract][Full Text] [Related]
22. Disinhibition of nigral GABA output neurons mediates muscular rigidity elicited by striatal opioid receptor stimulation.
Turski L; Havemann U; Schwarz M; Kuschinsky K
Life Sci; 1982 Nov 15-22; 31(20-21):2327-30. PubMed ID: 6298525
[TBL] [Abstract][Full Text] [Related]
23. Increase in striatal [3H]muscimol binding following intrastriatal injection of kainic acid: a denervation supersensitivity phenomenon.
Kuriyama K; Kurihara E; Ito Y; Yoneda Y
J Neurochem; 1980 Aug; 35(2):343-8. PubMed ID: 6256483
[TBL] [Abstract][Full Text] [Related]
24. Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat.
Wood PL
J Pharmacol Exp Ther; 1982 Sep; 222(3):674-9. PubMed ID: 6286931
[TBL] [Abstract][Full Text] [Related]
25. Correlation between rotational behaviors and neurochemical changes associated with damage of rat striatum: Analysis using unilateral microinjection of kainic acid.
Kuriyama K; Kurihara E
Neurochem Int; 1982; 4(6):551-5. PubMed ID: 20487910
[TBL] [Abstract][Full Text] [Related]
26. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ
Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098
[TBL] [Abstract][Full Text] [Related]
27. Role of globus pallidus GABA and opiate receptors in apomorphine circling in nigro-striatal lesioned rats.
Slater P
Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr; 319(1):43-7. PubMed ID: 6287299
[TBL] [Abstract][Full Text] [Related]
28. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
[TBL] [Abstract][Full Text] [Related]
29. Amphetamine-induced circling behavior in rats: effects of unilateral microinjections of GABA and GABA-related drugs into substantia nigra.
Thiébot MH; Soubrié P
Brain Res; 1979 May; 167(2):307-22. PubMed ID: 571751
[TBL] [Abstract][Full Text] [Related]
30. Enhanced GABA function in the angular complex (lateral periaqueductal grey matter and adjacent reticular formation) alters the postural component of striatal- or nigral-derived circling.
Reavill C; Muscatt S; Leigh PN; Jenner P; Marsden CD
Exp Brain Res; 1984; 56(1):1-11. PubMed ID: 6468558
[TBL] [Abstract][Full Text] [Related]
31. Transsynaptic effect of an intrastriatal fetal nigral graft on the sensitivity of the substantia nigra pars reticulata to muscimol in the rat.
Gaudin DP; St-Pierre JA; Lavoie B; Bédard PJ
Exp Neurol; 1994 May; 127(1):45-53. PubMed ID: 8200436
[TBL] [Abstract][Full Text] [Related]
32. Striato-nigral denervation increases type II benzodiazepine receptors in the substantia nigra of the rat.
Corda MG; Concas A; Porceddu ML; Sanna E; Biggio G
Neuropharmacology; 1986 Jan; 25(1):59-62. PubMed ID: 3005905
[TBL] [Abstract][Full Text] [Related]
33. Circling behavior induced by intranigral injections of GABA and muscimol in rats.
Kaakkola S; Kääriäinen I
Psychopharmacology (Berl); 1980; 68(1):31-6. PubMed ID: 6771796
[TBL] [Abstract][Full Text] [Related]
34. Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA.
Konieczny J; Czarnecka A; Kamińska K; Lenda T; Nowak P
Behav Brain Res; 2015 Apr; 283():203-14. PubMed ID: 25655509
[TBL] [Abstract][Full Text] [Related]
35. Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation.
Di Chiara G; Morelli M; Porceddu ML; Gessa GL
Life Sci; 1978 Nov; 23(20):2045-51. PubMed ID: 569236
[No Abstract] [Full Text] [Related]
36. Nigral actions of GABA agonists are enhanced by chronic fluphenazine and differentiated by concomitant flurazepam.
Coward DM
Psychopharmacology (Berl); 1982; 76(3):294-8. PubMed ID: 6808554
[TBL] [Abstract][Full Text] [Related]
37. Comparative behavioral and neurochemical studies with striatal kainic acid- or quinolinic acid-lesioned rats.
Vécsei L; Beal MF
Pharmacol Biochem Behav; 1991 Jun; 39(2):473-8. PubMed ID: 1719569
[TBL] [Abstract][Full Text] [Related]
38. GABA receptors distribution in rat substantia nigra.
De Montis GM; Olianas MC; Mulas G; Lloyd KG; Tagliamonte A
Neurosci Lett; 1981 May; 23(3):257-61. PubMed ID: 6267520
[TBL] [Abstract][Full Text] [Related]
39. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
Giambalvo CT; Snodgrass SR
Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
[TBL] [Abstract][Full Text] [Related]
40. Evidence that a nigral gabaergic--cholinergic balance controls posture.
De Montis GM; Olianas MC; Serra G; Tagliamonte A; Scheel-Krüger J
Eur J Pharmacol; 1979 Jan; 53(2):181-90. PubMed ID: 569589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
